Luman, the cellular counterpart of herpes simplex virus VP16, is processed by regulated intramembrane proteolysis.

Mol Cell Biol

Department of Veterinary Microbiology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5B4, Canada.

Published: August 2002

AI Article Synopsis

  • Luman is a transcription factor that requires the host cell factor HCF for its activity and is critical for cell growth, though its specific biological function is not entirely understood.
  • Luman is a type II membrane-associated glycoprotein that undergoes regulated intramembrane proteolysis (RIP), likely involving the site 1 protease (S1P) found in the Golgi apparatus.
  • The processing of Luman by S1P is influenced by treatments like brefeldin A, and alterations in specific amino acid sequences can prevent S1P cleavage, suggesting that further processing steps may be necessary for Luman to enter cell nuclei.

Article Abstract

Luman is a human basic leucine zipper transcription factor that, like the herpes simplex virus transcription factor VP16, requires the host cell factor, HCF, for activity. Although both HCF and Luman have been implicated in cell growth, their biological roles have not been clearly defined. Luman conforms to a type II membrane-associated glycoprotein with its carboxyl terminus embedded in cellular membranes and its amino terminus, which contains all its identified functional domains, in the cytoplasm. Here we show that Luman is processed by regulated intramembrane proteolysis (RIP). The site 1 protease (S1P), a Golgi apparatus-resident enzyme responsible for catalyzing the first step in the RIP pathway of the sterol regulatory element binding proteins (SREBPs) and ATF6, may also be involved in the processing of Luman. Thus, processing of Luman was highly stimulated by brefeldin A, a compound that causes the reflux of Golgi apparatus enzymes to the endoplasmic reticulum (ER). In addition, coexpression of Luman with S1P containing a KDEL ER retrieval signal resulted in virtually quantitative cleavage of Luman in the absence of any treatment. Finally, Luman contains a sequence, RQLR, immediately downstream from the transmembrane domain which bears similarity to the consensus S1P cleavage site identified by others. Substitution of arginine residues within this motif abolished S1P cleavage, providing robust evidence that S1P is involved in Luman processing. We observed that following S1P cleavage, the majority of the cleaved Luman was retained in cytoplasmic membranes, indicating that an additional step or enzymes yet to be identified are involved in complete cleavage and release to yield the product which ultimately enters the nuclei of cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC133973PMC
http://dx.doi.org/10.1128/MCB.22.16.5639-5649.2002DOI Listing

Publication Analysis

Top Keywords

luman
12
s1p cleavage
12
herpes simplex
8
simplex virus
8
processed regulated
8
regulated intramembrane
8
intramembrane proteolysis
8
transcription factor
8
processing luman
8
luman processing
8

Similar Publications

Introduction: Individuals with ADHD continue to face stigma, which can negatively impact their access to, adherence to, and quality of mental health services, as well as their overall wellbeing. Perspectives of various stakeholders regarding priorities for stigma reduction remain underexplored. This study explores young adult, parent, teacher, and mental health care professional perspectives on unmet needs of children and young adults with ADHD in the Netherlands, in the context of stigma reduction.

View Article and Find Full Text PDF

Stimulant medication is effective in alleviating overall symptom severity of attention-deficit/hyperactivity disorder (ADHD), yet interindividual variability in treatment response and tolerability still exists. While network analysis has identified differences in ADHD symptom relations, the impact of stimulant medication remains unexplored. Increased understanding of this association could provide valuable insights for optimizing treatment approaches for individuals with ADHD.

View Article and Find Full Text PDF
Article Synopsis
  • * Using both animal models (Sprague Dawley rats) and cell lines (BV-2 cells), researchers assessed how paeoniflorin impacts pain-related responses and inflammation markers, noting significant reductions in pain and inflammatory proteins.
  • * Results indicate that paeoniflorin relieves neuropathic pain by modulating interactions between microglia and astrocytes through specific pathways (HSP90AA1/HMGB1), highlighting its potential as a treatment option for neuropathic pain.
View Article and Find Full Text PDF

Placebo-related improvement with methylphenidate treatment in children with ADHD.

Eur Child Adolesc Psychiatry

August 2024

VU Amsterdam, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands.

Non-specific effects of methylphenidate treatment, including expectancy and regression to the mean effects, contribute to the overall effect of methylphenidate on attention-deficit/hyperactivity disorder (ADHD) symptoms. Knowledge on the extent to which non-specific effects contribute to the overall effect and whether regression to the mean explains part of the non-specific effects, is currently lacking. A double-blind, randomized, placebo-controlled, cross-over trial was used to compare parent and teacher ratings of child ADHD symptoms at baseline and during treatment with placebo and 5, 10, 15 and 20 mg of methylphenidate, twice daily.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!